Antitumor activity of chrysomycins M and V.
Matson
J A
JA
Pharmaceutical Research and Development Division, Bristol-Myers Company, Wallingford, Connecticut 06492-7660.
Rose
W C
WC
Bush
J A
JA
Myllymaki
R
R
Bradner
W T
WT
Doyle
T W
TW
D000617:Aminoglycosides; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D007942:Leukemia, Experimental / Q000188:drug therapy*; D051379:Mice
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; C035075:chrysomycin A; C036275:chrysomycin B